Devin Rhodenizer
Overview
Explore the profile of Devin Rhodenizer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanner A, Valencia C, Rhodenizer D, Espirages M, da Silva C, Borsuk L, et al.
J Mol Diagn
. 2014 Feb;
16(3):350-60.
PMID: 24517888
Identifying individuals as carriers of severe disease traits enables informed decision making about reproductive options. Although carrier screening has traditionally been based on ethnicity, the increasing ethnic admixture in the...
2.
Jones M, Rhodenizer D, da Silva C, Huff I, Keong L, Bean L, et al.
Mol Genet Metab
. 2013 Jun;
110(1-2):78-85.
PMID: 23806237
Congenital disorders of glycosylation (CDG) are comprised of over 60 disorders with the majority of defects residing within the N-glycosylation pathway. Approximately 20% of patients do not survive beyond five...
3.
Valencia C, Ankala A, Rhodenizer D, Bhide S, Littlejohn M, Keong L, et al.
PLoS One
. 2013 Jan;
8(1):e53083.
PMID: 23326386
The congenital muscular dystrophies (CMDs) comprise a heterogeneous group of heritable muscle disorders with often difficult to interpret muscle pathology, making them challenging to diagnose. Serial Sanger sequencing of suspected...
4.
Valencia C, Rhodenizer D, Bhide S, Chin E, Littlejohn M, Keong L, et al.
J Mol Diagn
. 2012 Mar;
14(3):233-46.
PMID: 22426012
Sequencing individual genes by Sanger sequencing is a time-consuming and costly approach to resolve clinically heterogeneous genetic disorders. Panel testing offers the ability to efficiently and cost-effectively screen all of...
5.
Jones M, Ng B, Bhide S, Chin E, Rhodenizer D, He P, et al.
Am J Hum Genet
. 2012 Feb;
90(2):363-8.
PMID: 22305527
Congenital disorders of glycosylation (CDG) are inherited autosomal-recessive diseases that impair N-glycosylation. Approximately 20% of patients do not survive beyond the age of 5 years old as a result of...
6.
Jones M, Bhide S, Chin E, Ng B, Rhodenizer D, Zhang V, et al.
Genet Med
. 2011 Aug;
13(11):921-32.
PMID: 21811164
Purpose: Congenital disorders of glycosylation are a heterogeneous group of disorders caused by deficient glycosylation, primarily affecting the N-linked pathway. It is estimated that more than 40% of congenital disorders...
7.
Martin I, Jones M, Rhodenizer D, Zheng J, Warrick J, Seroude L, et al.
Free Radic Biol Med
. 2009 Jun;
47(6):803-13.
PMID: 19545620
Oxidative damage to cell macromolecules by reactive oxygen species is associated with numerous diseases and aging. In Drosophila, RNAi-mediated silencing of the mitochondrial antioxidant manganese superoxide dismutase (SOD2) throughout the...
8.
Jones M, Gargano J, Rhodenizer D, Martin I, Bhandari P, Grotewiel M
Exp Gerontol
. 2009 Jun;
44(8):532-40.
PMID: 19481596
Age-related locomotor impairment (ARLI) is one of the most detrimental changes that occurs during aging. Elderly individuals with ARLI are at increased risks for falls, depression and a number of...
9.
Rhodenizer D, Martin I, Bhandari P, Pletcher S, Grotewiel M
Exp Gerontol
. 2008 Jun;
43(8):739-48.
PMID: 18515028
Age-related locomotor impairment in humans is important clinically because it is associated with several co-morbidities and increased risk of death. One of the hallmarks of age-related locomotor impairment in humans...